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Abstract
Background Althoughseveralchronicobstructivepulmonary
disease (COPD) practice guidelines have been published,
there is sparse data on the actual emergency department (ED)
management of acute exacerbation of COPD (AECOPD).
Aims Our objectives were to examine concordance of ED
care of AECOPD in older patients with guideline recom-
mendations and to evaluate whether concordance has
improved over time in two academic EDs.
Methods Data were obtained from two cohort studies on
AECOPD performed in two academic EDs during two
different time periods, 2000 and 2005–2006. Both studies
included ED patients, aged 55 and older, who presented
with AECOPD, and cases were confirmed by emergency
physicians. Data on ED management and disposition were
obtained from chart review for both cohorts.
Results The analysis included 272 patients: 72 in the 2000
database and 200 in the 2005–2006 database. The mean age
of the patients was 72 years; 50% were women and 80%
white. In 2005–2006, overall concordance with guideline
recommendations was high (for chest radiography, pulse
oximetry, bronchodilators, all ≥90%), except for arterial
blood gas testing (7% among the admitted) and discharge
medication with systemic corticosteroids (42%). Compared
to the 2000 data, the use of systemic corticosteroids in the
ED improved from 53 to 77% [absolute improvement:
24%, 95% confidence interval (CI): 11–37%], and the use
of antibiotics among the patients with respiratory infection
symptoms improved from 56 to 78% (absolute improvement:
22%, 95% CI: 6–38%).
Conclusions Overall concordance with guideline-
recommended care for AECOPD was high in two academic
EDs, and some emergency treatments have improved over
time.
Keywords Chronic obstructivepulmonarydisease.
Exacerbation.Guidelines.Qualityofcare
Introduction
Acute exacerbation of chronic obstructive pulmonary
disease (AECOPD) is a common presentation in the
emergency department (ED), with an estimated 600,000
ED visits in the USA in 2005 [1]. Despite its importance,
research on quality of AECOPD care has received
disproportionately less attention. Several COPD practice
guidelines are available and provide evidence-based rec-
ommendations on AECOPD care; however, the extent to
which actual ED practice follows guidelines is largely
unknown. We previously showed that concordance of ED
management of AECOPD with current treatment guidelines
was low at 29 North American EDs in 2000–2001 [2].
Since 2001, there have been several COPD guidelines
released, including the Global Initiative for Chronic
Obstructive Lung Disease guidelines published in 2001
[3] and updated annually [4], the 2001 American College of
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Aurora, CO, USAPhysicians guidelines [5], and the 2004 American Thoracic
Society and European Respiratory Society joint guidelines
[6]. It is unclear whether the publications of these guide-
lines have helped to improve guideline concordance in
AECOPD care over time.
In 2006, we conducted a chart review study on validation
of AECOPD administrative codes, which allowed us to
reexamine AECOPD care in two of the aforementioned 29
EDs [7]. The two objectives of our study were (1) to
investigate recent concordance of ED management of
AECOPD in older patients with guideline recommendations
in two academic EDs and (2) to evaluate whether the
concordance has improved from 2000–2001 to 2005–2006.
Methods
Study design
This study combined datafrom twocohort studies performed
during two different time periods, 2000 and 2005–2006.
Both were part of the Multicenter Airway Research
Collaboration in the Emergency Medicine Network (http://
www.emnet-usa.org).
Study population
The study conducted in 2006 was a retrospective cohort
study using a medical record review in two academic EDs
in Boston. Details of the study design and data collection
have been published previously [7]. In brief, using the
electronic medical records system at each site, we searched
the following International Classification of Diseases,
Ninth Revision, Clinical Modification (ICD-9-CM) codes
to identify possible ED visits for AECOPD from July 2005
to June 2006: 491.2 (obstructive chronic bronchitis), 492.8
(other emphysema), and 496 (chronic airway obstruction,
not elsewhere classified) in the primary diagnosis field. We
identified all ED visits with candidate ICD-9-CM codes for
patients age ≥55 years at each site, selected a random
sample of 100 visits from each institution (200 total), and
obtained written ED charts. We confirmed AECOPD status
by chart review consensus of two emergency physicians
(AAG and CAC). Detailed clinical information on the
current exacerbation, stable COPD history, ED management,
and ED disposition was collected from chart review.
The study conducted in 2000 was a multicenter
observational cohort study. To enhance the comparability
with the study conducted in 2006, we restricted the
multicenter cohort to patients who were enrolled in the
two aforementioned EDs in Boston. This would allow us to
examine the changes in the care provided by the same EDs
over time. Details of the study design and data collection of
this multicenter study have been published previously [2].
In brief, investigators at 29 EDs in 15 US states and 3
Canadian provinces provided 24-h/day coverage for a
median of 2 weeks. Inclusion criteria were physician
diagnosis of COPD; presenting to the ED for treatment of
Table 1 Recommendations for management of acute exacerbation of chronic obstructive pulmonary disease in major clinical guidelines
Process of Care American College of Chest Physicians &
American College of Physicians-American
Society of Internal Medicine guidelines
(2001) [5]
American Thoracic Society/
European Respiratory Society
guidelines (updated in 2004)
[6]
Global Initiative for Chronic
Obstructive Lung Disease (updated
in 2007) [4], strength of evidence
where indicated
Diagnostic evaluation
Chest radiography Recommended Recommended in admitted patients Recommended
Pulse oximetry Recommended Recommended Recommended
Arterial blood gas Not clearly addressed Recommended in admitted patients Recommended in admitted patients
Acute spirometry Not recommended Not addressed Not recommended
a
ED treatment
Inhaled bronchodilators Recommended Recommended Recommended (level A)
Systemic corticosteroids Recommended Recommended
b Recommended (level A)
Antibiotics Recommended in severe exacerbations Recommended in patients with altered
sputum purulence and/or volume
Recommended in patients with airway
infection (level B)
Methylxanthines Not recommended Not addressed
c Second-line therapy (level B)
d
Discharge medication
Systemic corticosteroids Recommended Recommended Recommended (level A)
ED emergency department, level A randomized controlled trials with rich body of data, level B randomized controlled trials with limited body of
data
aChanged from “not clearly addressed” in 2001 guidelines
bChanged from “may be added” in 1995 guidelines
cChanged from “primary agent” in 1995 guidelines
dChanged from “level A recommended treatment” in 2001 guidelines
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worsening cough, or change in sputum production [4, 6];
age ≥55 years; and the ability to give informed consent.
Patients’ demographics, stable COPD history, and details of
their current AECOPD were obtained by ED interview. Data
on ED management and disposition were obtained using
medical chart review. For those who did not complete ED
interview (missed by investigators, refused, or other reasons),
chart review was performed to abstract complete information
on demographics and ED management, along with limited
informationonstableCOPDhistoryandcurrentexacerbation.
For the chart review in both studies, trained chart
abstractors used a standardized form with precisely pre-
defined variables to collect data. Periodic meetings were
held to resolve coding issues and to monitor data collection.
Chart reviewers were blinded to the study hypothesis.
Repeat visits by individual subjects were excluded. The
Institutional Review Boards approved the studies.
Outcome measures
Concordance with guidelines: quality indicators
On the basis of recommendations contained in the COPD
guidelines [4–6], we categorized the following diagnostic
evaluations and treatments in the ED as beneficial: chest
radiography, pulse oximetry, arterial blood gas analysis,
inhaled bronchodilators (either short-acting beta-agonists or
inhaledanticholinergics),systemiccorticosteroids,antibiotics,
and discharge medications with systemic corticosteroids
(Table 1). Bronchodilator and systemic corticosteroid treat-
ments were recently included as quality measures in
pharmacotherapy for AECOPD in the Health Care Effec-
tiveness Data and Information Sets [8]. To better define the
patient population eligible for the quality indicators, we
restricted the denominator of arterial blood gas analysis to
admitted patients as appropriate candidates (i.e., severe
Table 2 Clinical characteristics and quality of care received among emergency department patients with an acute exacerbation of chronic
obstructive pulmonary disease, according to time period
Variables Period 1: 2000 (n=72) Period 2: 2005–2006 (n=200) Difference in means or proportions (95% CI)
Baseline clinical characteristic
Age, years 71±9 72±9 1 (−2t o3 )
Female sex 36/72 (50) 101/200 (51) 1 (−13 to 14)
White 58/68 (85) 156/200 (78) −7( −17 to 3)
Current or former smoker 68/71 (96) 154/183 (84) −12 (−5t o−19)
Home oxygen use 15/47 (32) 72/200 (36) 4 (−11 to 19)
Acute exacerbation
Duration of symptoms ≥ 24 h 56/69 (81) 138/164 (84) 3 (−8 to 14)
Triggered by respiratory infection 45/69 (65) 116/196 (59) −6( −19 to 7)
Respiratory rate, breaths/min 26±7 23±6 3 (1 to 5)
O2 saturation on room air, %
a 89±10 92±6 4 (1 to 7)
Process of care
Recommended
Chest radiography 72/72 (100) 196/200 (98) −2( −5t o3 )
Pulse oximetry 72/72 (100) 199/200 (99.5) −0.5 (−3t o5 )
Arterial blood gas
b 14/58 (24) 12/166 (7) −17 (−5t o−27)
Received inhaled bronchodilators in ED 59/71 (83) 180/200 (90) 7 (−3 to 17)
Received systemic corticosteroids in ED 38/72 (53) 154/200 (77) 24 (11 to 37)
Received antibiotics in ED
c 25/45 (56) 90/116 (78) 22 (6 to 38)
Sent home on systemic corticosteroids
d 6/11 (55) 13/31 (42) −13 (−22 to 47)
Not recommended
Spirometry
e 7/35 (20) 19/200 (10) −11 (−24 to 3)
Received methylxanthines in ED 0 0 0
ED disposition
Hospital admission
f 58/72 (81) 166/200 (83) 2 (−8 to 13)
ED emergency department
Data are presented as number/total number (percentage) or mean ± standard deviation, unless otherwise specified. For certain variables, the
sample size may vary because of missing data and/or restrictions to the denominators
aRestricted to room air oxygen saturations (n=53 for period 1, n=49 for period 2)
bRestricted to admitted patients
cRestricted to patients with respiratory infection symptoms
dRestricted to patients sent home from ED
eExcluded patients enrolled in a substudy of acute spirometry in the 2000 cohort to reflect normal clinical practice
fHospital admission was defined as admission to an inpatient unit, observation unit, or intensive care unit
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antibiotic use to patients with respiratory infection symptoms,
according to guideline recommendations [4–6]. Finally, we
considered evaluation by acute spirometry and treatment with
methylxanthine bronchodilators as not recommended [4–6].
Statistical analysis
Summary statistics are presented as proportions [with 95%
confidence intervals (CI)] or means [with standard deviations
(SD)]. The univariable associations between time period and
variables were examined using two-sample t-tests or tests of
proportions, as appropriate. To adjust for baseline patient
characteristics (patient mix) that may have confounded the
relationship between time period and quality indicators,
multivariable logistic regression modeling was performed.
Model variables included age, sex, race, duration of
symptoms, respiratory infection triggers, respiratory rate,
oxygen saturation on room air, and indicators for the two
time periods. Variables with missing data were dummy
coded using the missing-indicator method. All odds ratios
(OR) are presented with 95% CIs. All analyses were
performed using Stata v10.0 software (StataCorp, College
Station, TX, USA). All P values are two-sided, with P<0.05
considered statistically significant.
Results
Overall, 272 patients were included in the current analysis.
The mean age of these patients was 72 years (SD: 9); 50%
were women and 80% were white. There were 72 patients
with AECOPD in the 2000 database and 200 in the 2005–
2006 database. Of the 72 patients in 2000, 46 underwent
interview plus chart review and 26 underwent chart review
only. There were no significant differences in age, sex, or
race between the two cohorts (Table 2). Compared with
patients in the earlier study, patients in 2005–2006 were
less likely to be current or former smokers and presented to
the ED with lower acuity, as suggested by the lower
respiratory rates and the higher oxygen saturation on room
air. There were no significant differences in home oxygen
use, duration of symptoms, or respiratory infection triggers
between the two cohorts.
With respect to quality of emergency care, the use of chest
radiography, pulse oximetry, and bronchodilators was consis-
tently high during the study period (Table 2 and Fig. 1). In
contrast, the use of arterial blood gas testing among the
admitted decreased significantly from 24 to 7% (absolute
change: −17%, 95% CI: −5t o−27%). The use of systemic
corticosteroids in the ED increased significantly from 53% in
2000 to 77% in 2005–2006 (absolute improvement: 24%,
95% CI: 11–37%). Likewise, the use of antibiotics among the
patients with respiratory infection symptoms improved from
56 to 78% (absolute improvement: 22%, 95% CI: 6–38%).
The prescription of systemic corticosteroids at discharge,
however, was not high in either time period (<60%), and no
significant changes were observed during the study period.
With respect to ED management that is not guideline
recommended, there was a decreasing trend in the use of
acute spirometry, but this was not statistically significant.
Use of methylxanthines was not observed during the study
period. More than 80% of the patients were admitted, with
this high admission rate persisting during the study period.
The pattern of changes in the performance on quality
indicators remained after adjusting for small baseline
differences in patient characteristics between the two time
periods in the logistic regression models. For example, the
increasing trends in the use of systemic corticosteroids and
antibiotics in the ED persisted (adjusted OR for corticosteroid
use comparing 2005–2006 to 2000: 3.4, 95% CI: 1.7–7.0;
adjusted OR for antibiotic use: 4.3, 95% CI: 1.5–12.2).
Discussion
These data demonstrate overall high concordance of ED
management of AECOPD in older patients with guideline
recommendations in two academic EDs in Boston, except
for arterial blood gas testing and discharge medication with
systemic corticosteroids. In addition, we found significant
improvements in some guideline-recommended treatments,
including an increase in the ED use of systemic cortico-
steroids and antibiotics.
Fig. 1 Absolute change in performance on quality indicators for acute
exacerbation of chronic obstructive pulmonary disease among eligible
patients in the emergency departments. Asterisks indicate P<0.05.
CXR chest X-ray, Pul-ox pulse oximetry, ABG arterial blood gas, BD
bronchodilators, SC-ed systemic corticosteroids in the emergency
department, ABx antibiotics in the emergency department, SC-d
systemic corticosteroids at discharge, Spiro spirometry
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appeared to have reached the “ceiling” effect in the two
academic EDs, including the use of chest radiography, pulse
oximetry,andbronchodilators.Ontheother hand,the non-use
of methylxanthines and rare use of acute spirometry appeared
to have reached the “floor” effect, which also is encouraging.
Spirometry is often difficult to perform in the emergency
setting, and its accuracy is questionable [4, 5]. Therefore
acute spirometry should have a very limited role in
AECOPD [10].
The observed improvements in prescriptions of systemic
corticosteroids and antibiotics for AECOPD are consistent
with the national trends [1]. Furthermore, the prescription
rates of the medications in the two academic EDs were
better than the corresponding national averages in 2005
(national averages: 60% for systemic corticosteroids and
42% for antibiotics) [1]. This may suggest that the diffusion
of the guideline-recommended care has been relatively
successful in these two academic EDs. Continuous quality
improvement efforts, such as educational activities, should
help shift the average performance toward excellence.
A finding that is discordant with guideline recommen-
dations was the low use of arterial blood gas analysis;
however, this may reflect actual practice. Given that
oxygenation can be assessed by pulse oximetry and that
ventilation can be monitored by noninvasive capnography
[10], the low use of arterial blood gas analysis might be
acceptable. Alternatively, patients might receive this proce-
dure after their admission decisions were made (i.e., as
inpatients). This also might contribute to the low use of this
procedure in the ED. The low prescription of systemic
corticosteroids at ED discharge also is somewhat concerning,
a finding that needs to be confirmed in future studies with
more discharged patients.
This study has some potential limitations. First, the
guideline-concordant care is only reflective of emergency
care processes at two well-established teaching hospitals
and may not be fully generalizable to community
hospitals. Second, the data on quality of care were
obtained using medical record review for both cohorts,
and some of the quality deficit may be due to under-
documentation. However, previous studies of acute asthma
showed that the rates of ED assessments and treatments by
chart abstraction were similar to those by direct observa-
tion, with kappa coefficients ranging from 0.6 to 0.9 [11].
In addition, such underdocumentation would make it
difficult to explain both the increasing and the decreasing
trends that we identified during the study period. Finally,
there may be a Hawthorne effect created by the patient
enrollment process in the 2000 study (i.e., short-term
improvement due to observation). However, had this effect
been removed, the improving trend we observed would
have been more significant.
In summary, we found overall high concordance of ED
management of AECOPD with guideline recommendations
in two Boston academic EDs, with significant improve-
ments in some treatments between 2000 and 2006. In this
small sample of academic EDs, there remain opportunities
for improvement. Continuous quality improvement efforts
in refinement, dissemination, and implementation of clinical
practice guidelines may further improve quality of AECOPD
care. Future COPD guidelines should consider incorporating
these data to better reflect the ED aspect of AECOPD care.
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